scispace - formally typeset
U

Ujjwal Rathore

Researcher at Gladstone Institutes

Publications -  15
Citations -  4684

Ujjwal Rathore is an academic researcher from Gladstone Institutes. The author has contributed to research in topics: Immunogen & Epitope. The author has an hindex of 10, co-authored 13 publications receiving 2965 citations. Previous affiliations of Ujjwal Rathore include University of California, Berkeley & Indian Institute of Science.

Papers
More filters
Journal ArticleDOI

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.

David E. Gordon, +128 more
- 30 Apr 2020 - 
TL;DR: A human–SARS-CoV-2 protein interaction map highlights cellular processes that are hijacked by the virus and that can be targeted by existing drugs, including inhibitors of mRNA translation and predicted regulators of the sigma receptors.
Journal ArticleDOI

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.

David E. Gordon, +203 more
- 04 Dec 2020 - 
TL;DR: The authors identified shared biology and host-directed drug targets to prioritize therapeutics with potential for rapid deployment against current and future coronavirus outbreaks, and found that individuals with genotypes corresponding to higher soluble IL17RA levels in plasma are at decreased risk of COVID-19 hospitalization.
Posted ContentDOI

A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing

David E. Gordon, +123 more
- 22 Mar 2020 - 
TL;DR: The identification of host dependency factors mediating virus infection may provide key insights into effective molecular targets for developing broadly acting antiviral therapeutics against SARS-CoV-2 and other deadly coronavirus strains.
Journal ArticleDOI

Evaluation of SARS-CoV-2 serology assays reveals a range of test performance.

TL;DR: A head-to-head evaluation of ten point-of-care-style lateral flow assays and two laboratory-based enzyme-linked immunosorbent assays to detect anti-SARS-CoV-2 IgM and IgG antibodies in 5-d time intervals from symptom onset underline the importance of seropositivity threshold determination and reader training for reliable LFA deployment.
Journal ArticleDOI

Design of a non-glycosylated outer domain-derived HIV-1 gp120 immunogen that binds to CD4 and induces neutralizing antibodies.

TL;DR: ODEC is the first example of a gp120 fragment-based immunogen that yields significant neutralizing antibodies, and upon immunization in rabbits, ODEC was highly immunogenic, and the sera showed measurable neutralization for four subtype B and one subtype C virus including two b12-resistant viruses.